Any stock, in context
ALIVUS · Healthcare
Alivus Life Sciences Limited
Observation · 15 Oct 2026
How these are readAlivus Life Sciences closed at ₹1,341.8 on 15 Oct 2026, 22.3% above its 200-day average and 2.0% below its 50-day average: above the long line, below the short one. It sits 7.1% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 18.8%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +22.3%
- the long line
- vs 50-day
- −2.0%
- the short line
- From 52w high
- −7.1%
- ₹819.0₹1,493.8
- 3 months
- +18.8%
- sector median −2.7% · 21 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹11 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.46%
- 1W
- –
- 1M
- −0.44%
- 3M
- +18.82%
- YTD
- –
- 1Y
- +44.11%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.